CAS: 511-12-6 - dihydroergotamine

Formel: C₃₃H₃₇N₅O₅

InChl: InChI=1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1

InChI Key: InChIKey=LUZRJRNZXALNLM-JGRZULCMSA-N

SMILES: O=C(NC1(OC2(O)N(C1=O)C(C(=O)N3CCCC32)CC=4C=CC=CC4)C)C5CN(C)C6CC7=CNC8=CC=CC(=C87)C6C5

Synonyme:

• (5'Alpha,10Alpha)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman
• (5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione
• 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
• 9,10-Dihydroergotamine
• DHE
• Dihidroergotamina
• Dihydroergotamin
• Dihydroergotamine base
• Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'α,10α)-
• Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-
• Ergotamine, 9,10-dihydro-
• Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
• Levadex
• Map 0004

Dihydro Ergotamine Mesylate

CAS: 511-12-66190-39-2

• Formel: C₃₃H₃₇N₅O₅·CH₄O₃S
• Molekulargewicht: 583.69 96.11

Dihydro N-Ethyl Ergotamine

CAS: 511-12-6

• Formel: C₃₄H₃₇N₅O₅
• Farbe und Form: Neat
• Molekulargewicht: 595.688

Dihydroergotamine

CAS: 511-12-6

Dihydroergotamine is a drug used to treat migraine headaches. It is thought to act by …

• Reinheit: Min. 95%
• Farbe und Form: Powder
• Molekulargewicht: 583.68 g/mol

Levadex

CAS: 511-12-6

Applications Levadex is an intermediate in the synthesis of 2’-Epidihydroergotamine (E584910), which is an ergot …

• Formel: C₃₃H₃₇N₅O₅
• Molekulargewicht: 583.68